The importance of sterility testing
![](/46/pdcnewsitem/07/70/21/1902CHE%20-%20Sterility%20Testing%20eBook%20(1).jpg)
The user’s guide to regulatory expectations, the testing process, what to do in the event of test failure, and more.
Cherwell Laboratories, specialist suppliers of products for environmental monitoring and process validation, has published an eBook titled, “Failure is not an option: Why sterility testing is so important”, which is available to download from Cherwell’s website.
The guide offers a full overview of sterility testing including why the sterility test is such an important requirement for the manufacture of sterile products. It provides some practical steps that will help ensure the standards as set out by the European Pharmacopoeia and GMP are met. The eBook also addresses the role of environmental monitoring programs and how these are critical to successful sterility testing, product quality and business reputation.
Andy Whittard, Cherwell Laboratories’ Managing Director comments: “While we recognise that sterility testing is a critical step in ensuring that pharmaceutical products are safe for human use, we also all know that the test is not perfect. Therefore, we have put together this eBook to offer some guidance and practical steps to overcome the challenges involved with sterility testing. Our guide will help the reader mitigate the risk of sterility test failure for their facility by using better processes and continuous environmental monitoring methods.”
Topics covered within the eBook include the sterility test principle; what the expectations are within the pharmacopoeia and GMP; key considerations in the sterility testing process; how to tackle a sterility test failure and practical steps to minimise risk of contamination.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance